Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kobrin

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|March 1, 1994
Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitisH Friess, Y Yamanaka, M Büchler, et al.
Anticancer Research|May 1, 1993
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressivenessY Yamanaka, H Friess, M S Kobrin, et al.
Biochemical and Biophysical Research Communications|October 4, 1995
Increased expression of keratinocyte growth factor in human pancreatic cancerI Siddiqi, H Funatomi, M S Kobrin, et al.
Gut|October 1, 1994
Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gammaM Korc, H Friess, Y Yamanaka, et al.
Biochemical and Biophysical Research Communications|August 15, 1994
Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancerM S Kobrin, H Funatomi, H Friess, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1992
A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study GroupR Bain, R Rohde, L G Hunsicker, et al.
International Journal of Cancer|September 4, 1995
Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancerM Ebert, M Yokoyama, H Friess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progressionH Friess, Y Yamanaka, M S Kobrin, et al.
The Journal of Biological Chemistry|March 5, 1989
Transforming growth factor-alpha in the mammalian brain. Immunohistochemical detection in neurons and characterization of its mRNAJ E Kudlow, A W Leung, M S Kobrin, et al.
Endocrine Research Communications|January 1, 1982
The biological half-life of human growth hormone and a biologically active 20,000-dalton variant in mouse bloodM B Sigel, W P VanderLaan, M S Kobrin, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|March 1, 1994
Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitisH Friess, Y Yamanaka, M Büchler, et al.
Anticancer Research|May 1, 1993
Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressivenessY Yamanaka, H Friess, M S Kobrin, et al.
Biochemical and Biophysical Research Communications|October 4, 1995
Increased expression of keratinocyte growth factor in human pancreatic cancerI Siddiqi, H Funatomi, M S Kobrin, et al.
Gut|October 1, 1994
Chronic pancreatitis is associated with increased concentrations of epidermal growth factor receptor, transforming growth factor alpha, and phospholipase C gammaM Korc, H Friess, Y Yamanaka, et al.
Biochemical and Biophysical Research Communications|August 15, 1994
Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancerM S Kobrin, H Funatomi, H Friess, et al.
Journal of the American Society of Nephrology : JASN|October 1, 1992
A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study GroupR Bain, R Rohde, L G Hunsicker, et al.
International Journal of Cancer|September 4, 1995
Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancerM Ebert, M Yokoyama, H Friess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progressionH Friess, Y Yamanaka, M S Kobrin, et al.
The Journal of Biological Chemistry|March 5, 1989
Transforming growth factor-alpha in the mammalian brain. Immunohistochemical detection in neurons and characterization of its mRNAJ E Kudlow, A W Leung, M S Kobrin, et al.
Endocrine Research Communications|January 1, 1982
The biological half-life of human growth hormone and a biologically active 20,000-dalton variant in mouse bloodM B Sigel, W P VanderLaan, M S Kobrin, et al.
Pageof 6